Lantern Pharma Inc. (LTRN) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Lantern Pharma Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.280 Good afternoon and welcome to our fourth quarter and year end 2024 earnings call. 00:00:05.280 -- 00:00:10.470 As a reminder, this call is being recorded and all attendees are in a listen only mode. 00:00:10.470 -- 00:00:15.258 We will open the call for questions and answers after our management's presentation. 00:00:15.258 -- 00:00:20.628 A webcast replay of today's conference call will be available on our website at lanternpharma.com 00:00:20.628 -- 00:00:23.389 shortly after the call. 00:00:33.292 -- 00:00:36.919 order and year, ended December 31st, 2024. 00:00:36.919 -- 00:00:38.919 A 00:00:38.923 -- 00:00:43.532 copy of this release is available through our website at lanternpharma.com, 00:00:43.532 -- 00:00:47.400 where you will also find a link to the slides management we'll be referencing on today's 00:00:47.400 -- 00:00:53.516 call. We would like to remind everyone that remarks about future expectations, performance, 00:00:53.516 -- 00:00:58.671 estimates and prospects constitute forward-looking statements for purposes of safe harbor 00:00:58.671 -- 00:01:04.038 provisions under the Private Securities Litigation Reform Act of 1995. 00:01:04.038 -- 00:01:08.543 Lantern Pharma cautions that these forward looking statements are subject to risks and 00:01:08.543 -- 00:01:14.029 uncertainties that may cause actual results to differ materially from those anticipated. 00:01:14.029 -- 00:01:18.694 A number of factors could cause actual results to differ materially from those indicated 00:01:18.694 -- 00:01:23.439 by forward looking statements, including results of clinical trials and the impact of 00:01:23.439 -- 00:01:24.841 competition. 00:01:24.841 -- 00:01:29.506 Additional information concerning factors that could cause actua...